|
After completion of the merger, the combined company will develop Slate’s migraine treatment pipeline.
|
 |
|
The designation applies to those who have previously undergone platinum-based chemotherapy and an immune checkpoint inhibitor.
|
|
|
This new guidance provides doctors in the UK with another important treatment option for heart failure (HF).
|
|
|
Discover how GSK, Boehringer Ingelheim, Takeda and more than 100 pharma leaders scale digital projects at AUTOMA+ 2026 in Switzerland.
|
|
|
Sandoz and Henlius will collaborate on up to 10 biosimilars amid opportunity to capitalise on global biosimilar loss-of-exclusivities.
|
|
